Skip to main content

Peer Review reports

From: Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer

Original Submission
18 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
27 Apr 2021 Reviewed Reviewer Report
27 May 2021 Reviewed Reviewer Report - Heinz Schmidberger
28 May 2021 Reviewed Reviewer Report - Birsen Yucel
30 Jun 2021 Author responded Author comments - Xiao-Long Fu
Resubmission - Version 6
30 Jun 2021 Submitted Manuscript version 6
30 Oct 2021 Reviewed Reviewer Report - Birsen Yucel
22 Nov 2021 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
24 Nov 2021 Editorially accepted
22 Jan 2022 Article published 10.1186/s12885-021-09099-3

You can find further information about peer review here.

Back to article page